SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today launched research-grade ...

-- Launch of End-to-End Workflow for AVITI and AVITI24™ Enabling Sample to Sequencer in as Little as Five Hours -- -- Twist Gains Exclusive Access to the new, co-developed Trinity Freestyle™ ...

In early December 2025, Twist Bioscience launched research-grade Plasmid DNA Preps with animal origin-free and endotoxin-free options tailored to stringent preclinical study requirements. This move ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...

Catherine Ramsey Schulte, an analyst from Robert W. Baird, maintained the Buy rating on Twist Bioscience (TWST – Research Report). The associated price target is $38.00. Catherine Ramsey Schulte’s ...

Twist Bioscience (NASDAQ:TWST) is gearing up to announce its quarterly earnings on Monday, 2025-05-05. Here's a quick overview of what investors should know before the release. Analysts are estimating ...

On Monday, Twist Bioscience Corporation (NASDAQ:TWST) reported a fourth-quarter loss per share of 59 cents, beating the consensus loss of 70 cents. Twist Bioscience reported fourth-quarter sales of ...

Twist Bioscience has shown revenue growth from $54.4m in 2019 to potentially >$300m in 2024, but continues to post losses. Despite a diverse customer base and innovative synthetic DNA technology, ...

5 analysts have shared their evaluations of Twist Bioscience (NASDAQ:TWST) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table summarizes their ...

Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that its executives will participate ...

Paula Green, the Senior Vice President of Human Resources at Twist Bioscience Corp (NASDAQ:TWST), recently sold a portion of her holdings in the company. According to a filing with the Securities and ...